LRP4 autoantibodies have been proved to be pathogenic, as demonstrated in mice immunized with the extracellular domain of LRP4, which develop anti-LRP4 antibodies and exhibit MG-like symptoms [24]. Here, LRP4 is linked to myasthenia gravis.